ATE152733T1 - Bradykinin-antagonisten zur behandlung von akuter pankreatitis - Google Patents

Bradykinin-antagonisten zur behandlung von akuter pankreatitis

Info

Publication number
ATE152733T1
ATE152733T1 AT92121558T AT92121558T ATE152733T1 AT E152733 T1 ATE152733 T1 AT E152733T1 AT 92121558 T AT92121558 T AT 92121558T AT 92121558 T AT92121558 T AT 92121558T AT E152733 T1 ATE152733 T1 AT E152733T1
Authority
AT
Austria
Prior art keywords
gly
hyp
pro
substituted
benzoyl
Prior art date
Application number
AT92121558T
Other languages
German (de)
English (en)
Inventor
Thomas Dr Griesbacher
Fred Prof Dr Lembeck
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of ATE152733T1 publication Critical patent/ATE152733T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT92121558T 1991-12-21 1992-12-18 Bradykinin-antagonisten zur behandlung von akuter pankreatitis ATE152733T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91122055 1991-12-21

Publications (1)

Publication Number Publication Date
ATE152733T1 true ATE152733T1 (de) 1997-05-15

Family

ID=8207466

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92121558T ATE152733T1 (de) 1991-12-21 1992-12-18 Bradykinin-antagonisten zur behandlung von akuter pankreatitis

Country Status (27)

Country Link
US (1) US5670619A (OSRAM)
EP (1) EP0548825B1 (OSRAM)
JP (1) JP3588472B2 (OSRAM)
KR (1) KR930012034A (OSRAM)
CN (1) CN1073603A (OSRAM)
AT (1) ATE152733T1 (OSRAM)
AU (1) AU662188B2 (OSRAM)
BG (1) BG97168A (OSRAM)
BR (1) BR9205062A (OSRAM)
CA (1) CA2085781C (OSRAM)
CY (1) CY2116B1 (OSRAM)
CZ (1) CZ375692A3 (OSRAM)
DE (1) DE69219574T2 (OSRAM)
DK (1) DK0548825T3 (OSRAM)
ES (1) ES2101017T3 (OSRAM)
FI (1) FI925782L (OSRAM)
GR (1) GR3024179T3 (OSRAM)
HU (1) HU214056B (OSRAM)
IL (1) IL104163A0 (OSRAM)
MA (1) MA22743A1 (OSRAM)
MX (1) MX9207440A (OSRAM)
NO (1) NO924925L (OSRAM)
PL (1) PL297044A1 (OSRAM)
SI (1) SI9200406A (OSRAM)
TW (1) TW199863B (OSRAM)
YU (1) YU108192A (OSRAM)
ZA (1) ZA929829B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105172B1 (en) 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
US20040248809A1 (en) * 2003-02-07 2004-12-09 Aventis Pharma Deutschland Gmbh Use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis
RU2400263C1 (ru) * 2009-04-28 2010-09-27 Евгений Петрович Измайлов Способ консервативного и физиотерапевтического лечения острого панкреатита
RU2425669C1 (ru) * 2010-04-13 2011-08-10 Общество С Ограниченной Ответственностью "Гамаветфарм" Средство для профилактики и лечения острого и хронического панкреатита

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55500520A (OSRAM) * 1978-07-18 1980-08-14
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
US4801613A (en) * 1985-06-13 1989-01-31 Nova Technology Limited Partnership Bradykinin antagonist peptides
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
US5162497A (en) * 1987-09-24 1992-11-10 The Administrators Of The Tulane Educational Fund Bradykinin analogs with non-peptide bond
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE69012142D1 (de) * 1989-12-08 1994-10-06 Univ Boston Acylierte bradykininantagonisten und deren verwendung.
EP0451791A2 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft Langwirksame Liposomenpräparate von Peptidarzneistoffen und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
GR3024179T3 (en) 1997-10-31
FI925782A0 (fi) 1992-12-18
IL104163A0 (en) 1993-05-13
EP0548825B1 (en) 1997-05-07
FI925782A7 (fi) 1993-06-22
EP0548825A1 (en) 1993-06-30
DE69219574T2 (de) 1997-11-13
JPH05255107A (ja) 1993-10-05
KR930012034A (ko) 1993-07-20
DE69219574D1 (de) 1997-06-12
HU9204074D0 (en) 1993-04-28
YU108192A (sh) 1995-12-04
CZ375692A3 (en) 1993-12-15
HU214056B (en) 1997-12-29
CA2085781C (en) 2003-09-23
BR9205062A (pt) 1993-09-28
MX9207440A (es) 1993-07-01
US5670619A (en) 1997-09-23
NO924925L (no) 1993-06-22
AU3021292A (en) 1993-06-24
MA22743A1 (fr) 1993-07-01
DK0548825T3 (da) 1997-11-03
TW199863B (OSRAM) 1993-02-11
ZA929829B (en) 1994-02-16
AU662188B2 (en) 1995-08-24
CY2116B1 (en) 2002-04-26
CA2085781A1 (en) 1993-06-22
BG97168A (bg) 1993-12-24
ES2101017T3 (es) 1997-07-01
FI925782L (fi) 1993-06-22
JP3588472B2 (ja) 2004-11-10
CN1073603A (zh) 1993-06-30
PL297044A1 (en) 1993-09-06
NO924925D0 (no) 1992-12-18
SI9200406A (en) 1993-06-30
HUT63336A (en) 1993-08-30

Similar Documents

Publication Publication Date Title
ATE171712T1 (de) Neuartiger menschlicher proteaseinhibitor vom kunitz-typ und entsprechende varianten
ATE219103T1 (de) Cnp-analoge peptide und ihre verwendung
UA35636C2 (uk) Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
Krstenansky et al. Development of MDL 28,050, a small stable antithrombin agent based on a functional domain of the leech protein, hirudin
ES2054365T3 (es) Inhibicion de la via de la regla del n final en celulas vivas.
ATE198603T1 (de) Bivalente thrombininhibitore
DE69219574D1 (de) Bradykinin-Antagonisten zur Behandlung von akuter Pankreatitis
ATE401070T1 (de) Aminosäuren-enthaltende zusammensetzungen, geeignet zur wundheilung, insbesondere zur behandlung des auges
ATE3416T1 (de) Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
ES2135398T3 (es) Compuesto y composiciones de inhibicion de la resorcion osea.
ATE408415T1 (de) Inhibitoren für die gefässneubildung
RU92016227A (ru) Лекарственная композиция, включающая антагонисты брадикинина, используемая в лечении острого панкреатита, способ ее получения и использование
TH13940A (th) เบรดีไคนิน-แอนตาโกนิส สำหรับใช้บำบัดตับอ่อน?อักเสบเฉียบพลัน
JPH10130163A (ja) アルツハイマー病の治療および予防用医薬の製造のためのブラジキニン拮抗薬の使用
ES541194A0 (es) Un procedimiento de preparacion de inhibidores de la renina que contienen estatina o sus derivados.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification